Weight loss was 6.0% (6.4 kg), 4.7% (5.0 kg), and 2.0% (2.2 kg) with liraglutide 3.0 mg, liraglutide 1.8 mg, and placebo, respectively
Digestive Issues Women with Lipedema already have higher rates of: IBS Constipation Bloating SIBO (small intestinal bacterial overgrowth) Slow digestion GLP-1s slow gastric emptying even further, which can increase: Constipation Gastroparesis Reflux Nausea If digestive issues are present, they ideally should be addressed before starting GLP-1s
Patients choose us for our steady communication, safe titration, and a program built around their lifenot the other way around
3 Results demonstrated that two intranasal formulations achieved up to seven times higher median plasma concentrations than the oral tablet, with lower variability in plasma levels
The 5mg vial is the most commonly tested size